Every one of those 1 sits in a single category, medical-devices. Of the tracked stories, 1 of 1 also mention Alcon, the most common co-covered peer. Source depth averages 2 original sources per story, versus 4 across the same-window beat baseline.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Allison Transmission
Every one of those 1 sits in a single category, medical-devices. Of the tracked stories, 1 of 1 also mention Alcon, the most common co-covered peer. Source depth averages 2 original sources per story, versus 4 across the same-window beat baseline. The 5 average consequence score is below the beat benchmark of 5.7 in the same window. Allison Transmission appears in 1 tracked Healthcare story from February 25, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 31 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Allison Transmission. Shared-story counts are live from our verified record — not editorial picks.
Alcon reported a Q4 core EPS of $0.78, narrowly missing the FactSet consensus of $0.79. While the miss was marginal, it highlights the ongoing pressure on medical device margins and the defensive posture of the healthcare sector compared to industrial peers.